Saturday 7 November 2026
Export OKUR’s income statement to Excel — free account
OnKure Therapeutics, Inc.
OKUR Healthcare Biotechnology
- EPS
- +67.2%
- Free cash flow
- +22.1%
Quarter to September 2026, against a year earlier
2.79
0.26
+10.28%
Follow OKUR
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
Current Ratio |
+8 more quarters Free account |
10.28 | 13.78 | 26.75 | 18.84 |
Net Debt/EBITDA |
4.24 | 12.46 | 10.56 | 8.54 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.85 | 0.85 | 0.67 | 0.73 | |
Capex/Depreciation |
(0.04) | (0.02) | (0.02) | (0.14) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(0.85) | (0.95) | (0.21) | (0.26) | |
Cash per Share |
4.37 | 14.05 | 3.54 | 3.27 | |
Shareholders Equity per Share |
4.16 | 13.48 | 3.45 | 3.16 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
4.16 | 13.48 | 3.45 | 3.16 | |
Free Cash Flow |
(11.52) | (12.94) | (10.36) | (13.11) | |
Working Capital |
54.92 | 183.15 | 171.03 | 156.80 | |
Capital Expenditures |
(0.01) | 0.00 | 0.00 | (0.03) | |
Net Current Asset Value |
54.91 | 183.14 | 170.43 | 156.25 | |
| Other line items | |||||
Quick Ratio |
9.97 | 13.41 | 26.55 | 18.58 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.85) | (0.95) | (0.21) | (0.26) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Payables |
2.20 | 6.68 | 2.19 | 1.80 | |
Average Assets |
88.51 | 149.29 | 132.71 | 119.96 | |
Average Common Equity |
80.01 | 137.50 | 125.14 | 112.08 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates · fundamentals updated 6 Nov 2026